Raising the bar of efficacy for drug approval requires an understanding of patient diversity.
Berger
Marc L
ML
Eck
Stephen
S
Ruberg
Stephen J
SJ
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D007206:Individuality; D009369:Neoplasms / Q000188:drug therapy; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents